Percutane Treatment of Heart-Valve-Diseases

 

  • Albertinen Herz- und Gefäßzentrum
  • Albertinen Herz- und Gefäßzentrum

 

Interventional aortic valve implantations (TAVI), transfemoral, transapical, transaortal and transjugular and treatment of mitral regurgitation by Mitra clip.

 

Patients with valvular heart disease and high surgical risk can be treated percutaneously (with catheter techniques). In most cases this is done via the femoral vessels, in any case on the beating heart, thus avoiding cardiopulmonary bypass. The most common procedures are interventional aortic valve implantations (TAVI), mostly from transfemoral, alternatively from transapical, transaortal or via the subclavian artery. Mitral valve procedures are performed transvenously for the treatment of insufficiency by utilizing the Mitra clip or annuloplasty devices. Severe tricuspid insufficiency can be  treated by annuloplasty or by Clipping as well.


The range of valve diseases that can be treated percutaneously in our department is unusually broad. It comprises

 

■ aortic valve stenosis
■ aortic valve insufficiency
■ mitral valve stenosis
■ mitral valve insufficiency
■ more recently, the tricuspid regurgitation (in studies)
■ the leak of flap edges (paravalvular leaks) after successful valve replacement.

Moreover shunts are sealed (patent foramen ovale) as atrial or ventricular septal defects.

In patients with atrial fibrillation the left atrial appendage may also be closed by means of catheter technique, to prevent oral anticoagulation (anticoagulants).

 

For all these interventions, we use the most modern methods. We have a variety of prosthetic heart valves available, enabling us  to tailor the treatment to the specific need for each individual patient.

 

  Prof Dr Joachim Schofer, MD
Head of the Department for Percutaneous Treatment of Valvular Heart Disease

 

 

Results and Figures

 

 

> Inquire for treatment options >

 

 

 

 

linie

 

 

newsletter

 

May We Send You Our Newsletter?

Stay informed on interesting news from the Albertinen Cardiovascular Centre and the latest developments on the subject of heart medicine.


 

 

get in touch

 

Get in Touch: Inquire for Evaluation and Treatment Options

You could imagine being treated for your heart condition at the Albertinen Cardiovascular Centre? Here is how you can get in touch with us. > read more

 

 

get in touch

 

Learn about Treatment Options for High Risk Patients

Patients with valvular heart disease and high surgical risk can be treated percutaneously (with catheter techniques). > read more

 

 

Vascular surgery

 

VIDEO: Vascular Surgery - Treatment of Complicated Abdominal Aortic Aneurysms

Due to the exponentially increasing risk of rupture abdominal aortic aneurysms beginning from a diameter of 5 cm should be eliminated ... > read more

 


 

Schofer

 

World Premiere at Albertinen Cardiovascular Centre

World's first reconstruction of a leaky tricuspid valve with the help of a catheter technique  > read more

 


 

lightroom

 

Reception, Accommodation, Care

The "two-man rule" at Albertinen Cardiovascular Centre creates the conditions for the optimal treatment of our patients.  > read more

 

 

studie

 

Scientific Projects and Research

In addition to the best possible patient care scientific projects are carried out to improve methods of treatment. > Learn about our research

 

 

Telefon

 

25 Years Heartmedicine at Albertinen Cardiovascular Centre

Cardiac surgery, interventional cardiology and cardiac anaesthesia at Albertinen Cardiovascular Centre in Hamburg are celebrating their 25th anniversary this year. The first heart operation here was performed on July 2, 1991. > read more 

 

 

 

 

 

 

Rieß

 

Prof Dr Friedrich-Christian Rieß, MD
Chairman of the Albertinen Cardiovalcular Centre
Chief Physician Cardiac Surgery
Phone +49-40-5588-2445
email

curriculum vitae | publications

 

Schlizio

 

Office
Süntelstraße 11a · 22457 Hamburg

 

Mrs. P. Schlizio
Phone +49-40-5588-2442
fax +49-40-5588-2421
E-mail

 

Oers

 

Mrs. S. van Oers
Phone +49-40-5588-2453
fax +49-40-5588-2421
E-mail

 

Oers

 

Mrs. K. Borchert

Phone +49-40-5588-2445
fax +49-40-5588-2421

E-mail

 

Stripling

 

Prof Dr Joachim Schofer, MD
Head of the Department for Percutaneous Treatment of Valvular Heart Disease
Phone +49-40-5588--2442 /-2453 /-2445
E-mail

 

 

 

Office

Mrs. A. Prach
Phone +49-40-889 00 91 52
Fax +49-40-889 00 99 33
E-mail

 

 

Hansen

 

Dr L. Hansen, MD
Deputy Physician Cardiac Surgery
Phone +49-40-5588-2445
E-mail

 

Winkel

 

S. Winkel
Deputy Physician Cardiac Surgery
Phone +49-40-5588-2445
E-mail

 

Stripling

 

J. Stripling
Deputy Physician Cardiac Surgery
Phone +49-40-5588-2445
E-mail

 

Rieß

 

Daniel Silva
Senior Physician Cardiac Surgery
Phone +49-40-5588-2445 
E-mail

 

 

Dr G. Horoschun, MD
Deputy Physician Cardiac Surgery Intensive Care C2h 
Phone +49-40-5588-2550 
E-mail

 

 

Dipl. Ing. R. Binczyk
Chief Perfusionists
OR-Manager

Phone +49-40-5588-2569
fax +49-40-5588-2569
E-mail

 

 

Kammin

 

B. Kliche
Head Nurse Cardiac Surgery
Phone +49-40-5588-6715
E-mail

 

 

 

Anniversary

Matthias Scheller, CEO of Albertinen Diakoniewerk e.V., congratulates the founding father of Albertinen Cardiovascular Centre, Professor W. Füllbrandt and the men of the first hour at the anniversary "25 Years Heart Medicine at Albertinen-Hospital"

 

 

From left: M. Scheller, Prof. W. Füllbrandt, Prof. F.-C. Rieß, J. Kormann, Dr. P. Kremer, Prof. N. Bleese. Photo: Andreas Riess

 

 

Anniversary

July 1, 2016 - Tobias Schwarz, CEO of Albertinen hospital, congratulates Mr. Joachim Kormann, Dr. Peter Kremer, MD, Mr. Stephan Winkel and Dr Christine Löwer, MD (from left) marking the 25th anniversary of service.

 

 

Photo: Andreas Riess

 

 

patientenuni

 

 

 

focus